Pojala Ciprian Vasile, Toma Sebastian, Costache Cristea, Peter Tunde, Pojala Cristiana Elena, Roman Nadinne Alexandra, Dima Lorena
Department of Fundamental, Preventive, and Clinical Disciplines, Faculty of Medicine, Transilvania University of Brasov, 500036 Brasov, Romania.
Department of Radiology and Medical Imaging, The University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Clin Pract. 2024 Sep 25;14(5):1970-1996. doi: 10.3390/clinpract14050157.
Knee osteoarthritis (KOA) is a common degenerative and progressive joint disorder that negatively influences patients' quality of life. Intra-articular therapies, such as hyaluronic acid (HA) and platelet-rich plasma (PRP), have garnered attention for their potential to manage osteoarthritis OA symptoms effectively. This systematic review aims to identify the effectiveness and safety of HA and PRP treatment modalities in treating KOA.
A literature search was conducted across MEDLINE (PubMed), Web of Science Core Collection, and Science Direct Collection Elsevier. Twenty-three randomized controlled trials, cohort studies, and observational studies were included in the review. The selection criteria focused on studies published in English within the last 10 years, involving subjects with KOA treated with intra-articular injections of HA or PRP and reporting on pain, function, or overall treatment efficacy outcomes.
The analysis showed that both HA and PRP significantly improve functionality and reduce pain in KOA patients. High molecular weight HA consistently reduced pain and improved joint mobility in various studies. PRP had better long-term outcomes when combined with HA, leading to greater pain reduction and functional improvement. Both therapies had generally favorable safety profiles, with only minor adverse events reported. However, there were potential biases identified across the studies, such as selection, performance, detection, and reporting biases, which impacted the reliability of the results.
Intra-articular treatments with HA and PRP show promise in managing knee osteoarthritis, with personalized treatment plans and further research needed to confirm these findings.
膝关节骨关节炎(KOA)是一种常见的退行性和进行性关节疾病,对患者的生活质量有负面影响。关节内治疗,如透明质酸(HA)和富血小板血浆(PRP),因其有效管理骨关节炎(OA)症状的潜力而受到关注。本系统评价旨在确定HA和PRP治疗方式在治疗KOA中的有效性和安全性。
在MEDLINE(PubMed)、科学引文索引核心合集和爱思唯尔科学Direct合集数据库中进行文献检索。本评价纳入了23项随机对照试验、队列研究和观察性研究。选择标准侧重于过去10年内发表的英文研究,这些研究涉及接受关节内注射HA或PRP治疗的KOA患者,并报告疼痛、功能或总体治疗效果结果。
分析表明,HA和PRP均能显著改善KOA患者的功能并减轻疼痛。在各项研究中,高分子量HA持续减轻疼痛并改善关节活动度。PRP与HA联合使用时具有更好的长期效果,能更大程度地减轻疼痛并改善功能。两种治疗方法总体安全性良好,仅报告了轻微不良事件。然而,研究中发现了潜在的偏倚,如选择偏倚、实施偏倚、检测偏倚和报告偏倚,这些偏倚影响了结果的可靠性。
HA和PRP关节内治疗在管理膝关节骨关节炎方面显示出前景,需要个性化治疗方案和进一步研究来证实这些发现。